Receive Insights and Updates for Providers by email
Clinical Stabilization Services notification update
Effective Jan. 1, 2026, providers of clinical stabilization services will be expected to complete admission notifications within 72 hours for certain members.
Billing update for residential substance use disorder treatment
Effective Jan. 1, 2026, form CMS-1500 and POS code 55 will be required for residential substance use disorder treatment for Tufts Health RITogether members.
Updated billing guidance for dental anesthesia
We’ve expanded our RITogether oral health benefits to include the use of dental anesthesia in a professional (office) setting.
Provider Service Center reminders
We are sharing a few updates for our provider partners to keep in mind regarding provider servicing.
Pharmacy coverage changes
Review this chart for information about updates to Point32Health's Pharmacy program and Pharmacy Medical Necessity Guidelines.
Coverage changes for Remicade and biosimilars
Effective Jan. 1, 2026, Avsola and Inflectra will be the preferred infliximab products. Remicade and unbranded Infliximab will become non-preferred products.
Prior authorization updates for Targeted Immunomodulators
Effective Jan. 1, 2026, we're making extensive updates to criteria and requirements associated with targeted immunomodulator medications.
MassHealth updates to Unified Formulary
Providers should be aware that updated coverage and criteria for the MassHealth Unified Formulary will be available on or after Nov. 17, 2025.
Point32Health Medical Necessity Guideline updates
Providers and office staff can refer to the following chart with updates to our Medical Necessity Guidelines.
Point32Health medical drug program updates
The following chart outlines updates to our prior authorization and clinical review program for medical benefit drugs.